{
  "docId": "019dd923-5fec-763b-95d0-6c2b37f81466",
  "docSlug": "bi-9523b367be63361f",
  "documentTitle": "3T Biosciences 27-slide pitch deck to raise $40M Series A",
  "authorId": "Pitchdecks",
  "authorName": "3T Biosciences",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.6,
  "pageNumber": 22,
  "pageCount": 27,
  "prevPage": 21,
  "nextPage": 23,
  "slideType": "solution",
  "function": "present_solution",
  "density": "overcrowded",
  "nDataPoints": 6,
  "notes": "The slide illustrates a data-driven platform architecture connecting patient samples/TCRs to specific tumor types and HLA classes.",
  "elementsJson": [
    "headline_text",
    "paragraph",
    "callout_box",
    "process_diagram"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5fec-763b-95d0-6c2b37f81466/22",
  "deckHref": "/decks/019dd923-5fec-763b-95d0-6c2b37f81466",
  "deckJsonHref": "/decks/019dd923-5fec-763b-95d0-6c2b37f81466.json",
  "deckAnchorHref": "/decks/019dd923-5fec-763b-95d0-6c2b37f81466#slide-22",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Active machine learning predicts immunogenic targets with 92% accuracy.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-c0aa-76ce-98c1-84023549acdb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.55,
        "x": 0.42,
        "y": 0.2
      },
      "kind": "diagram",
      "text": "Database of Shared TCRs, Tumor types, HLA types, and platform metrics.",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5450ad56-ae46-4393-9fa4-88ad31b6b1b1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.5,
        "x": 0.45,
        "y": 0.2
      },
      "kind": "metric",
      "text": "> 100 patient samples, > 190,000 TCRs, ~ 50% PD-1 responders",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "27fb18ea-18bc-4685-8b2d-24a8b0bf74eb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.5,
        "x": 0.45,
        "y": 0.75
      },
      "kind": "metric",
      "text": "40 billion unique peptides, multi-length libraries, 200 TCRs/month",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3427ba7e-1c2d-4bb4-8cda-3b2eb29d5ccf",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "accuracy: 92%",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd952-c0aa-76ce-98c1-8954637834da",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.35,
        "x": 0.045,
        "y": 0.45
      },
      "kind": "paragraph",
      "text": "In addition, the expanded coverage and scale of the technology applies across all tumor types, including ovarian, lung, colorectal, melanoma, breast and renal cell cancer.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "27714df4-6908-4c33-a9d0-584b9fed3cf0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.35,
        "x": 0.045,
        "y": 0.65
      },
      "kind": "paragraph",
      "text": "Active machine learning predicts immunogenic targets with 92% accuracy.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "75f9e699-d762-4d02-a1df-12fdb4dfe5b7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.35,
        "x": 0.045,
        "y": 0.25
      },
      "kind": "paragraph",
      "text": "3T-TRACE applies a yeast display platform and active machine learning to identify novel targets and T-cell receptors (TCRs). This includes the most prevalent and immunogenic targets in solid tumors.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7f1bca3e-29c9-4755-b92f-c076075532bc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.29,
        "x": 0.045,
        "y": 0.09
      },
      "kind": "title",
      "text": "3T TRACE Platform",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f28bd467-6048-4012-8bc0-fd64c6d7c263",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Audience Definition",
      "slug": "audience-definition",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "44b0c81e-de96-441d-bf27-b6c53cdee65f",
      "evidence": "paragraph/paragraph: In addition, the expanded coverage and scale of the technology applies across all tumor types, including ovarian, lung, colorectal, melanoma, breast and renal cell cancer.",
      "confidence": 0.5
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}